Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2282529rdf:typepubmed:Citationlld:pubmed
pubmed-article:2282529lifeskim:mentionsumls-concept:C0235032lld:lifeskim
pubmed-article:2282529lifeskim:mentionsumls-concept:C1882598lld:lifeskim
pubmed-article:2282529lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:2282529lifeskim:mentionsumls-concept:C0025991lld:lifeskim
pubmed-article:2282529lifeskim:mentionsumls-concept:C0205263lld:lifeskim
pubmed-article:2282529lifeskim:mentionsumls-concept:C0037239lld:lifeskim
pubmed-article:2282529pubmed:issue1-2lld:pubmed
pubmed-article:2282529pubmed:dateCreated1991-3-21lld:pubmed
pubmed-article:2282529pubmed:abstractTextMicroinjection of the D-1 agonist R-SKF 38393 into rat striatum resulted in extensive neurotoxic damage as revealed by the presence of large lesions upon histological analysis. These lesions were observed following a single injection of the drug into the ventrolateral striatum (30 micrograms/0.5 microliters) or nucleus accumbens (3.0 or 30 micrograms/0.5 microliters). This neurotoxic damage was also observed following microinjection of the inactive isomer S-SKF 38393. The mechanisms underlying these effects are presently unknown. The use of this compound for intracerebral microinjection studies should be re-evaluated. In view of the usefulness of central microinjections in studying the role of D-1 and D-2 receptors in behavior, it is suggested that alternative D-1 agonists, or ways of minimizing the toxicity of SKF 38393, should be considered.lld:pubmed
pubmed-article:2282529pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2282529pubmed:languageenglld:pubmed
pubmed-article:2282529pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2282529pubmed:citationSubsetIMlld:pubmed
pubmed-article:2282529pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2282529pubmed:statusMEDLINElld:pubmed
pubmed-article:2282529pubmed:monthNovlld:pubmed
pubmed-article:2282529pubmed:issn0006-8993lld:pubmed
pubmed-article:2282529pubmed:authorpubmed-author:KelleyA EAElld:pubmed
pubmed-article:2282529pubmed:authorpubmed-author:CidLLlld:pubmed
pubmed-article:2282529pubmed:authorpubmed-author:DelfsJ MJMlld:pubmed
pubmed-article:2282529pubmed:issnTypePrintlld:pubmed
pubmed-article:2282529pubmed:day5lld:pubmed
pubmed-article:2282529pubmed:volume532lld:pubmed
pubmed-article:2282529pubmed:ownerNLMlld:pubmed
pubmed-article:2282529pubmed:authorsCompleteYlld:pubmed
pubmed-article:2282529pubmed:pagination342-6lld:pubmed
pubmed-article:2282529pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:2282529pubmed:meshHeadingpubmed-meshheading:2282529-...lld:pubmed
pubmed-article:2282529pubmed:meshHeadingpubmed-meshheading:2282529-...lld:pubmed
pubmed-article:2282529pubmed:meshHeadingpubmed-meshheading:2282529-...lld:pubmed
pubmed-article:2282529pubmed:meshHeadingpubmed-meshheading:2282529-...lld:pubmed
pubmed-article:2282529pubmed:meshHeadingpubmed-meshheading:2282529-...lld:pubmed
pubmed-article:2282529pubmed:meshHeadingpubmed-meshheading:2282529-...lld:pubmed
pubmed-article:2282529pubmed:meshHeadingpubmed-meshheading:2282529-...lld:pubmed
pubmed-article:2282529pubmed:meshHeadingpubmed-meshheading:2282529-...lld:pubmed
pubmed-article:2282529pubmed:meshHeadingpubmed-meshheading:2282529-...lld:pubmed
pubmed-article:2282529pubmed:year1990lld:pubmed
pubmed-article:2282529pubmed:articleTitleNeurotoxicity induced by the D-1 agonist SKF 38393 following microinjection into rat brain.lld:pubmed
pubmed-article:2282529pubmed:affiliationDepartment of Psychology, Harvard University, Cambridge, MA 02138.lld:pubmed
pubmed-article:2282529pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2282529pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2282529lld:pubmed